Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02823652 · ClinicalTrials.gov registry record · NA

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

A NA study, sponsored by ECOG-ACRIN Cancer Research Group.

Completed
Registry status
NA
Development phase
601
Enrollment target

NCT02823652 is a NA study that has completed, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 601 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02823652, a NA study, has completed, sponsored by ECOG-ACRIN Cancer Research Group.

COMPLETED
Registry status
NA
Development phase
601 participants
Enrollment target

Study Summary

This research trial studies how well pre-test genetic education and remote genetic counseling works in communicating tumor profiling results to patients with advanced cancer. Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potential germline mutations may increase genetic knowledge and reduce distress for patients with advanced cancer.

Interventions

  • OTHER Survey Administration
  • OTHER Genetic Testing
  • OTHER Internet-Based Intervention
  • OTHER Genetic Counseling
  • OTHER standard genetic education

Trial Details

FieldValue
Enrollment Target 601 participants
Start Date 2016-10-25
Est. Completion 2019-12-26
Phase NA

Sponsor

ECOG-ACRIN Cancer Research Group

75 total trials

What the Registry Record Tells You About NCT02823652

The ClinicalTrials.gov registry entry for NCT02823652 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.

NCT02823652 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02823652 about?

NCT02823652 is a clinical study titled "Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer". This research trial studies how well pre-test genetic education and remote genetic counseling works in communicating tumor profiling results to patients with advanced cancer. Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potentia...

What is the current status of trial NCT02823652?

This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2016-10-25. Estimated completion is 2019-12-26.

What interventions are being tested in trial NCT02823652?

The interventions under investigation include: Survey Administration (OTHER), Genetic Testing (OTHER), Internet-Based Intervention (OTHER), Genetic Counseling (OTHER), standard genetic education (OTHER).

Who is sponsoring clinical trial NCT02823652?

This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.